Summary
A bicenter study compared survival probability in patients with malignant melanoma clinical stage I, treated by wide excision only or wide excision with elective lymph node dissection (ELND). ELND improved the survival only in men with primary tumors of 1.51–3.0 mm thickness. In female patients those without ELND showed a better survival. Thus, the total group of patients did not benefit from ELND, i.e. its value for the improvement of survival from malignant melanoma stage I could not be statistically proven.
This is a preview of subscription content, log in via an institution to check access.
Abbreviations
- ELND:
-
elective lymph node dissection
References
Balch CM (1980) Surgical management of regional lymph nodes in cutaneous melanoma. J Am Acad Dermatol 3: 511–524
Balch CM, Murad TM, Soong SJ, Ingalls AL, Richards PC, Maddox WA (1979) Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer 43: 883–888
Balch CM, Soong SJ, Milton GW, Shaw HM, McGovern VJ, Murad TM, McCarthy WH, Maddox WA (1982) A comparison of prognostic factors and surgical results in 1786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg 196 (6):677–684
Blois MS, Sagebiel RW, Abarbanel RM, Caldwell TM, Tuttle MS (1983) Malignant melanoma of the skin. I. The association of the tumor depth and type, and patient sex, age, and site with survival. Cancer 52: 1330–1341
Breslow A (1970) Thickness, cross sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172: 902–908
Cascinelli N, Morabito A, Bufalino R, van der Esch EP, Preda F, Voglin M, Rovini D, Orefice S (1980) Prognosis of stage I melanoma of the skin. WHO collaborating centers for evaluation of methods of diagnosis and treatment of melanoma. Int J Cancer 26: 733–739
Clark JR, From L, Bernardino EA, Mihm MC (1969) The histogenesis an biologic behavior of primary human malignant melanoma of the skin. Cancer Res 29: 705–726
Day C, Lew RA (1985) Malignant melanoma prognostic factors 7: elective lymph node dissection. J Dermatol Surg Oncol 11: 233–239
Drepper H, Grootens A, Padberg G, Peters A, Wiebelt H (1988) Prognoserelevante Kriterien und stadiengerechte Therapie des malignen Melanoms. In: Schwenzer N, Pfeifer G (eds) Fortschritte der Kiefer- und Gesichtschirurgie, Bd XXXIII. Thieme, Stuttgart New York, S 143–148
Heite HJ (1981) Ergebnisse der Arbeitgsgemeinschaft Malignes Melanom. Hautarzt (suppl V) 32: 11–19
Kühnl-Petzoldt C, Berger H, Wiebelt H (1983a) Malignes Melanom: Prognostische Beurteilung durch Korrelationskoeffizienten. Hautarzt 34: 398–402
Kühnl-Petzoldt C, Wiebelt H, Berger H (1983b) Prognostic groups of patients with stage I melanoma. Arch Dermatol 119: 816–818
Löhnert JD, Bongartz G, Wernecke K, Peters PE, Macher E, Brökker EB (1988) Sensitivität und Spezifität der sonographischen Lymphknotendiagnostik beim malignen Melanom. Radiologe 28: 317–319
McCarthy WH, Shaw HM, Milton GW (1985) Efficacy of elective lymph node dissection. Surg Gynecol Obstet 161: 575–580
Milton GW, Shaw HM, McCarthy WH, Pearson L, Balch CM, Soong SJ (1982) Prophylactic lymph node dissection in clinical stage I cutaneous malignant melanoma: results of surgical treatment in 1319 patients. Br J Surg 69: 108–111
Reintgen DS, Cox EB, McCarthy KS, Vollmer RT, Seigler HF (1983) Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg 198(3):379–385
Shaw HM, McGovern VJ, Milton GW, Farago GA, McCarthy WH (1980) Histologic features of tumors and the female superiority in survival from malignant melanoma. Cancer 45: 1604–1608
Sim FH, Taylor WT, Ivins JC, Pritchard DJ, Soule EH (1978) A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Cancer 41: 948–956
Sim FH, Taylor WT, Pritchard DJ, Soule EH (1986) Lymphadenectomy in management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 61: 679–705
SPSS (1984) Handbuch der Programmversion 2. Dtsch. Ausg. bearb. von Schubö W und Uehlinger HM. Fischer, Stuttgart New York
UICC (1978) TNM-Classification of malignant tumors, 3rd edn. Springer, Berlin Heidelberg New York
Veronesi U, Adamus J, Bandiera DC, Brennhovd IO, Caceres E, Cascinelli N, Claudio F, Ikonopisov L, Javorskj VV, Kirov S, Kulakowski A, Lacour J, Lejeune F, Szczygiel K, Trapeznikov NN, Wagner RI (1977) Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 297: 627–630
Veronesi U, Adamus J, Bandiera DC, Brennhovd IO, Caceres E, Cascinelli N, Claudio F, Ikonopisov L, Javorskj VV, Kirov S, Kulakowski A, Lacour J, Lejeune F, Mechl Z, Morabito A, Rodé I, Sergeev S, van Slooten E, Szczygiel K, Trapeznikov NN, Wagner RI (1982) Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 49: 2420–2430
Veronesi U, Bufalino R, Cascinelli N, Morabito A (1984) Long term results of randomized trial comparing immediate versus delayed node dissection in stage I melanoma of the limbs. Dev Oncol 25: 165–180
Author information
Authors and Affiliations
Additional information
Dedicated to Prof. E. Macher to the occasion of his 65th birthday
Rights and permissions
About this article
Cite this article
Bieß, B., Bröcker, E.B., Drepper, H. et al. Should elective lymph node dissection be used for treatment of primary melanoma?. J Cancer Res Clin Oncol 115, 470–473 (1989). https://doi.org/10.1007/BF00393340
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00393340